[144] IONIS PHARMACEUTICALS INC SEC Filing
Rhea-AI Filing Summary
IONS filed a Form 144 reporting proposed sales of Common Stock by an affiliate. The filing lists securities tied to option exercises dated 01/02/2024, 01/03/2023, and 01/03/2022 with quantities 10,461, 4,145, and 5,500, and Restricted Stock Units dated 01/13/2024 totaling 15,937 shares.
The filing also discloses recent sales by Shannon Devers: 44,199 shares on 01/07/2026 ($3,756,915.00), 8,353 shares on 01/16/2026 ($636,626.00), and 3,977 shares on 01/22/2026 ($323,490.00).
Positive
- None.
Negative
- None.
Insights
Form 144 notifies a planned resale of affiliate-held common stock and records recent insider sales.
The filing itemizes securities associated with option exercises and RSUs with explicit quantities and dates. It also documents executed sales by a named holder with share counts and gross proceeds listed in the excerpt.
These disclosures are procedural notices under resale rules; timing and methods of any future sales are not specified in the provided excerpt.